Sort
27,075 grants matching “cholesterol”
Glycomics of Heart and Lung Disease in the Genomic Era
$592,187Muredach P Reilly · University Of Pennsylvania · U01 · FY2014 · HL
Solid State NMR Studies of Membrane Proteins
$592,155Robert Guy Griffin · Massachusetts Institute Of Technology · R01 · FY2010 · EB
In Vivo Photoactoustic Sensing of Lipid Laden Plaque
$591,880Ji-Xin Cheng · Purdue University · R01 · FY2015 · HL
Role of Microglia in Cerebral Small Vessel Disease (CSVD)/Vascular Cognitive Impairment (VCI)
$591,839Jonathan R Weinstein · University Of Washington · R01 · FY2024 · NS
Prescribing Smart Aging: Integrating Health Systems with Community-Based Lifestyle Interventions
$591,790Jeffrey Murray Burns · University Of Kansas Medical Center · R01 · FY2017 · AG
Statins as Adjunctive, Host-Directed Therapy for TB
$591,785Petros C Karakousis · Johns Hopkins University · UH2 · FY2016 · AI
Biophysics of HDL Dysfunction
$591,775Kirkwood A Pritchard · Medical College Of Wisconsin · R01 · FY2015 · HL
Candidate Genes Affecting Adolescent Metabolic Syndrome
$591,748Ahmed H Kissebah · Medical College Of Wisconsin · R01 · FY2008 · DK
Nonviral Delivery of CRISPR-Cas9 into Hepatocytes Combined with APAP Selection for Treatment of Familial Hypercholesterolemia
$591,640Renee Nicole Cottle · Clemson University · R01 · FY2024 · HL
Levothyroxine Dosing in Older Individuals
$591,612Anne R Cappola · University Of Pennsylvania · R01 · FY2023 · AG
Genetics of high serum triglycerides and related metabolic traits in Mexicans
$591,547Paivi Pajukanta · University Of California Los Angeles · R01 · FY2013 · HL
Impact of phosphate and FGF23 reduction on intermediate end points in CKD
$591,523Tamara Isakova · Northwestern University At Chicago · R01 · FY2016 · DK
Neutrophil Survival and Demise During Inflammatory States
$591,469Harold M Hoffman · Scripps Research Institute, The · P01 · FY2025 · HL
Heart Matters: Collaborate and Leverage Evidence in an African American Rural Network to Implement Risk Reduction Strategies for CVD (Heart Matters: Co-Learn to Reduce CVD)
$591,338Gaurav J Dave · Univ Of North Carolina Chapel Hill · R01 · FY2023 · HL
Metabolic Reprogramming by Protease-activated Receptor 2
$591,270Athan Kuliopulos · Tufts Medical Center · R01 · FY2023 · DK
The effects of PD-1 on tumor-mediated âemergencyâ myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunity
$591,222Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2023 · CA
The effects of PD-1 on tumor-mediated âemergencyâ myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunity
$591,222Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2022 · CA
Sleep and Cardiovascular Health
$591,060Phyllis C Zee · Northwestern University At Chicago · R01 · FY2009 · HL
Diabetes and Aging in a Multi-Ethnic Population
$591,045Andrew John Karter · Kaiser Foundation Research Institute · R01 · FY2009 · DK
TMEM55B as a molecular determinant of NAFLD
$591,003Marisa Wong Medina · University Of California, San Francisco · R56 · FY2023 · DK
Soft drusen in rhesus macaques as a nonhuman primate model of early age-related macular degeneration
$590,988Glenn Yiu · University Of California At Davis · R01 · FY2021 · EY
Hemoglobin A1C Variability as a Risk Factor for Diabetes Complications
$590,922Paul R Conlin · Harvard Medical School · R01 · FY2019 · DK
Insulin Resistance, Inflammation and Vascular Remodeling
$590,917Allison B Goldfine · Beth Israel Deaconess Medical Center · P50 · FY2012 · HL
PET/MRI to study nanotherapy in atherosclerosis
$590,721Willem Mulder · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · HL
PET/MRI to study nanotherapy in atherosclerosis
$590,721Willem Mulder · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · HL